{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:54:02Z","timestamp":1762444442442},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jbspin.2013.12.007","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T14:25:27Z","timestamp":1390487127000},"page":"374-375","source":"Crossref","is-referenced-by-count":8,"title":["Gout in French Polynesia: A survey of common practices"],"prefix":"10.1016","volume":"81","author":[{"given":"Tristan","family":"Pascart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwan","family":"Oehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9-Marc","family":"Flipo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2013.12.007_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jbspin.2010.02.027","article-title":"The genetic basis of hyperuricaemia and gout","volume":"78","author":"Merriman","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2013.12.007_bib0010","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.24938","article-title":"Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand M\u0101ori, Pacific Island, and Caucasian case-control sample sets","volume":"60","author":"Hollis-Moffatt","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2013.12.007_bib0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0049-0172(81)90101-3","article-title":"Epidemiology of rheumatic disorders in the Pacific with particular emphasis on hyperuricaemia and gout","volume":"11","author":"Prior","year":"1981","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2013.12.007_bib0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10067-012-2110-5","article-title":"The experience and impact of gout in M\u0101ori and Pacific people: a prospective observational study","volume":"32","author":"Dalbeth","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2013.12.007_bib0025","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s10067-013-2402-4","article-title":"Gout: from international guidelines to current practice. Results from a physician questionnaire","volume":"32","author":"Pascart","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2013.12.007_bib0030","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/rheumatology\/ket158","article-title":"Primary care providers\u2019 knowledge, beliefs and treatment practices for gout: results of a physician questionnaire","volume":"52","author":"Harrold","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2013.12.007_bib0035","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2013.12.007_bib0040","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and anti-inflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2013.12.007_bib0045","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","article-title":"EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2013.12.007_bib0050","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X13002935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X13002935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T04:28:01Z","timestamp":1538886481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X13002935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1297319X13002935"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2013.12.007","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}